MaxCyte, Inc. Cell & Gene Tech Expo August 2025: Cell Therapy
Source: MaxCyte, Inc.
Cell and gene therapies are revolutionizing treatments for cancer and other serious diseases, but immune cell engineering remains difficult due to their sensitivity and resistance to standard transfection. MaxCyte’s ExPERT™ electroporation platform offers a highly efficient, scalable solution for delivering mRNA, DNA, and CRISPR-Cas9 RNPs into hard-to-transfect cells. This talk highlights optimized workflows that streamline cell engineering from discovery to clinical and commercial production.
        access the Video!
        
            Log In
        
    
    
    
    Get unlimited access to:
            Trend and Thought Leadership Articles
             
        
        
            Case Studies & White Papers
             
        
        
            Extensive Product Database
             
        
        
            Members-Only Premium Content
             
        
    
        Welcome Back! Please Log In to Continue.
        
            X
        
    
    Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
        Subscribe to Cell & Gene
        X
    
    
        Subscribe to Cell & Gene
    
    